Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis

Circulation Research
H Shimokawa, P M Vanhoutte

Abstract

Vasoconstrictor responses are augmented in porcine coronary arteries in hypercholesterolemia and atherosclerosis, leading to an occurrence of coronary vasospasm in the latter condition. The role of the endothelium in the vascular hyperreactivity in hypercholesterolemic and atherosclerotic coronary arteries was examined, particularly in response to aggregating and related vasoactive substances. Male Yorkshire pigs underwent balloon endothelial denudation of the left anterior descending coronary artery (LAD) and 2% high-cholesterol feeding for 10 weeks. Electron microscopic examination demonstrated a full lining of endothelial cells in the LAD and the left circumflex coronary artery (LCX). Endothelium-dependent responses were examined in vitro. In cholesterol-fed animals, endothelium-dependent relaxations to aggregating platelets, serotonin, ADP, bradykinin, thrombin, and the calcium ionophore A23187 were depressed in LAD (atherosclerosis), while the relaxations to aggregating platelets, serotonin and ADP were depressed in LCX (hypercholesterolemia). Serotonin-induced contractions were endothelium-dependently augmented in atherosclerotic LAD; the endothelium-dependent component of the contractions was inhibited by blockers of cyc...Continue Reading

References

Nov 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·R BusseE Bassenge
Jan 1, 1986·Annual Review of Physiology·P M VanhoutteD S Houston
Jun 1, 1986·British Journal of Pharmacology·H AzumaS Sekizaki
Oct 23, 1986·The New England Journal of Medicine·P L LudmerP Ganz
Apr 1, 1987·British Journal of Pharmacology·B FurlongJ A Smith
Feb 20, 1986·The New England Journal of Medicine·R Ross
Feb 1, 1987·Circulation Research·L JayakodyT Kappagoda
Dec 1, 1987·The Journal of Clinical Investigation·D G HarrisonD D Heistad
Oct 1, 1985·Circulation·P M Vanhoutte, D S Houston
Jul 1, 1985·The Journal of Physiology·G M Rubanyi, P M Vanhoutte
Jul 1, 1985·The American Journal of Physiology·G M RubanyiP M Vanhoutte
Jun 1, 1969·Experimental and Molecular Pathology·B F Miller, H V Kothari
Nov 1, 1983·Circulation Research·R F Furchgott
Jan 1, 1983·The Journal of Clinical Investigation·M L ArmstrongF M Abboud
Mar 1, 1981·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S M SchwartzS C Selden
Aug 1, 1980·The Journal of Clinical Investigation·P D Henry, M Yokoyama

❮ Previous
Next ❯

Citations

Dec 1, 1992·Clinical Cardiology·F E KuhnC E Rackley
Jan 1, 1990·Cardiovascular Drugs and Therapy·P M Vanhoutte
Jun 1, 1989·Cardiovascular Drugs and Therapy·M J Davies
Nov 1, 1993·Cardiovascular Drugs and Therapy·P RubbaM Mancini
May 1, 1994·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·J R Bender
Aug 7, 2010·Cardiovascular Drugs and Therapy·Paul M Vanhoutte
Dec 1, 1994·British Journal of Plastic Surgery·G Burnstock, V Ralevic
May 16, 1990·European Journal of Pharmacology·A Namiki, N Akatsuka
Nov 27, 1990·European Journal of Pharmacology·T J VerbeurenA G Herman
Jan 1, 1995·Molecular Aspects of Medicine·M J Halpern
Feb 1, 1993·Trends in Pharmacological Sciences·D Salvemini, R Botting
Jan 1, 1990·General Pharmacology·J Marín, C F Sánchez-Ferrer
Jan 1, 1990·General Pharmacology·C F Sánchez-Ferrer, J Marín
Mar 1, 1990·Journal of the American College of Cardiology·T F LüscherC Boulanger
Aug 1, 1993·Journal of the American College of Cardiology·J R TeerlinkJ P Clozel
Aug 1, 1994·Journal of the American College of Cardiology·T J AndersonA C Yeung
May 1, 1994·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·R CirilloM Prosdocimi
Jul 1, 1991·Trends in Cardiovascular Medicine·T F LüscherF C Tanner
May 29, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Haim TapieroKenneth D Tew
Nov 24, 1995·The American Journal of Cardiology·P M VanhoutteJ V Mombouli
Sep 2, 1998·The Annals of Thoracic Surgery·C I ChardignyJ N Fabiani
Jul 4, 1998·European Journal of Pharmacology·D J GrieveJ Elliott
Jan 1, 1997·Progress in Cardiovascular Diseases·H Drexler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.